Crossref
Targeting glycolytic GARP+ fibroblasts alleviates B cell-Th2 crosstalk-driven fibrosis in pancreatic adenocarcinoma
Cancer Communications · 16.11.2026
DOI: 10.34133/cancomm.0077 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Communications, online erschienen am 16.11.2026. Verfasst von Mahepali Mahabati und 11 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Mahabati, M., Cao, W., Jian, Z., Feng, Y., Ren, Y., Wu, Y., Jiang, H., Wu, R., Wu, C., Huang, C., Lao, X., & Wei, Y. (2026). Targeting glycolytic GARP+ fibroblasts alleviates B cell-Th2 crosstalk-driven fibrosis in pancreatic adenocarcinoma. Cancer Communications. https://doi.org/10.34133/cancomm.0077
Vancouver
Mahabati M, Cao W, Jian Z, Feng Y, Ren Y, Wu Y, et al. Targeting glycolytic GARP+ fibroblasts alleviates B cell-Th2 crosstalk-driven fibrosis in pancreatic adenocarcinoma. Cancer Communications. 2026. doi:10.34133/cancomm.0077
BibTeX
@article{Mahabati2026,
author = {Mahabati, Mahepali and Cao, Wen-Jie and Jian, Zhi-Wei and Feng, Yu-Hui and Ren, Yi-Zheng and Wu, Yong-Yi and Jiang, Hong-Fei and Wu, Rui-Qi and Wu, Cai-Yuan and Huang, Chun-Xiang and Lao, Xiang-Ming and Wei, Yuan},
title = {Targeting glycolytic GARP+ fibroblasts alleviates B cell-Th2 crosstalk-driven fibrosis in pancreatic adenocarcinoma},
journal = {Cancer Communications},
year = {2026},
doi = {10.34133/cancomm.0077}
}
EUVIMED